Homology Medicines, Inc. is a Bedford-based biotechnology company dedicated to developing one-time treatments for genetic disorders. With a mission-focused approach, they aim to provide innovative solutions to the rare disease community through their broad genetic medicines platform, which includes gene therapy and gene editing technologies.
As a leader in the field, Homology Medicines is actively engaged in clinical trials for various genetic diseases such as PKU and MPS II. Their commitment to advancing genetic medicine is evident through their partnerships, pipeline of potential treatments, and continuous efforts to improve the lives of individuals affected by genetic disorders.
Generated from the website